Search the Newsreel

VivoSim Labs, Inc. (VIVS) Stock Price, News, Quote & History

This article provides a comprehensive overview of VivoSim Labs, Inc. (VIVS) stock, including its real-time price, historical data, and key financial metrics. It details the company's profile as a biotechnology firm specializing in 3D human tissue models for drug testing and development. The report …

Shattuck Labs Inc (STTK) Stock News Today

This article provides current stock information for Shattuck Labs Inc (STTK), including its stock price, market cap, and a note that more news is coming soon. As of the close on August 7th, STTK was trading at $7.270, up 1.54%.

Establishment Labs (NASDAQ: ESTA) lifts H1 2026 revenue 37.5% but stays in loss

Establishment Labs (NASDAQ: ESTA) reported strong revenue growth for the first half of 2026, with revenue increasing by 37.5% to $127.4 million, primarily driven by U.S. sales. Despite this growth and an improved gross margin of 70.7%, the company remained unprofitable, posting a net …

Blend Labs (BLND) Head of Revenue sells 15,041 shares in 10b5-1 trade

Matthew Christopher Thomson, Blend Labs' Head of Revenue, sold 15,041 shares of Class A Common Stock on August 5, 2026, at a weighted average price of $2.004 per share. This transaction, executed under a Rule 10b5-1 trading plan adopted on March 16, 2026, leaves …

Blend Head of Revenue Matthew Thomson disposes of 15,041 common shares worth $30,147.16

Matthew Christopher Thomson, Blend Labs' Head of Revenue, sold 15,041 Class A common shares for $30,147.16 on August 5th, at a weighted average price of $2 per share. Following this transaction, Thomson's direct holdings in the company decreased to 60,162 shares. The information for …

Proto Labs Inc (PRLB) Stock News Today

This page provides the latest news, earnings, analyst ratings, and key developments for Proto Labs Inc (PRLB) stock. It highlights a recent earnings report from Q2 2026, where Protolabs announced record revenue driving margin expansion. The page also displays current stock performance data and …

Planet Labs PBC (PL) co-founder gifts 55,000 Class A shares

Robert H. Schingler, Co-Founder and Chief Strategy Officer of Planet Labs PBC (PL), reported a bona fide gift of 55,000 Class A Common Stock shares on August 5, 2026, from the Ulysses Trust 02021.1, for which no value was received. Following this transaction, the …

Aarti Pharmalabs director Rajendra Gogri steps down

Blend Labs Inc (BLND) Stock News Today

Blend Labs Inc (BLND) Earnings Forecast: Future EPS & Revenue Growth Estimates

MOBIX LABS, INC. (MOBX) Stock News Today

Wells Fargo & Company Issues Pessimistic Forecast for Blend Labs (NYSE:BLND) Stock Price

Absci Corp (ABSI) Stock News Today

This article from TradingKey provides current stock information for Absci Corp (ABSI), a biotechnology and medical research company. It includes the stock's current price, daily change, market capitalization, and indicates that more news, earnings, analyst ratings, and key developments will be available soon.

Establishment Labs Holdings Inc. Stock 12‑Month Price Target Raised to $101.22, Implies 11% Upside

Nine analysts have raised the average 12-month price target for Establishment Labs Holdings Inc. (ESTA) stock from $97.22 to $101.22, representing an approximately 11% potential upside based on the August 5th closing price. The consensus rating for the stock remains a "Buy," with 8 …

Is Planet Labs PBC (PL) Priced For Perfection After Its Huge Run?

Is Planet Labs PBC (PL) Stock Too Stretched To Be Reasonable?

Establishment Labs Holdings Releases Q2 2026 Financial Results

Establishment Labs Holdings reported Q2 2026 financial results, missing analyst expectations for earnings with a net loss of $0.39 per share, despite strong revenue growth of 31.7% to $67.5 million. The company showed progress towards breakeven with a narrowed loss per share year-over-year and …

Establishment Labs Holdings Inc (ESTA) (Q2 2026) Earnings Call Highlights: U.S. Sales Surge 140. ...

Establishment Labs Holdings Inc (ESTA) reported strong Q2 2026 results, with total revenue up 31.7% year-over-year to $67.5 million, significantly driven by a 140.9% surge in U.S. sales to $24.7 million. The company achieved positive Adjusted EBITDA of $3.7 million, a substantial improvement from …

Australian Clinical Labs Ltd (ASX: ACL) Share Price Update: Stock Declines as Health Care Index Ends Lower

Astera Labs Inc Stock (ALAB) Moved Up by 5.30% on Aug 6: Drivers Behind the Movement

Astera Labs Inc. (ALAB) stock rose 5.30% due to strong institutional demand for AI connectivity hardware and upward revisions of price targets by analysts. The company benefits from its dominant market share in high-speed signal integrity technology solutions, addressing data bottlenecks in AI infrastructure. …

Blend Announces Second Quarter 2026 Financial Results

Blend Labs, Inc. announced its second-quarter 2026 financial results, reporting revenue near the high end and non-GAAP operating income above the high end of its guidance. The company also highlighted the commercial availability of its "Autopilot" product, with six lenders already signed on, and …

VivoSim Labs Regains Nasdaq Compliance After $6M Milestone and $4M Financing

VivoSim Labs announced it has regained compliance with Nasdaq's minimum stockholders’ equity rule following a $5.0 million milestone payment from Eli Lilly, the release of $1.0 million from escrow, and a $4.0 million financing completed in July 2026. The company reported approximately $10.1 million …

BIOAGE Labs Inc (BIOA) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for BIOAGE Labs Inc (BIOA), highlighting an earnings forecast score of 8.44 and an average price target of $12.00. Based on ratings from 9 analysts, the stock is predominantly recommended as a "Buy." Key financial expectations include an …

BIOAGE Labs Inc (BIOA) Stock News Today

Noticias de acciones de Astera Labs Inc (ALAB)

Is Aurora Labs (ASX:A3D) Facing a Cash Runway Test?

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Establishment Labs (NASDAQ:ESTA) Stock

Astera Labs beats a weak chip group while a 23% four-week slide keeps conviction in check

ALAB rose 6.7% in the latest week and ranks near the top of US Semiconductors on a 12-week view, but the recovery remains uneven after a sharp July reset and only baseline-level participation.

GeoVax Labs Inc (GOVX) Earnings Forecast: Future EPS & Revenue Growth Estimates

GeoVax Labs Inc (GOVX) has an earnings forecast score of 8.00, ranking 171 out of 387 in its industry. Analysts have set an average price target of $8.50, with a significant upside potential of over 10000% based on two analysts' Buy recommendations. The company's …

A Quick Look at Today's Ratings for BioAge Labs(BIOA.US), With a Forecast Between $21 to $73

This article provides a brief overview of recent analyst ratings for BioAge Labs (BIOA.US), highlighting a wide forecast range for its stock price between $21 and $73. It indicates that these ratings come from investment analysts who are evaluating the company's future performance.

Earnings call transcript: Blend Labs beats Q2 revenue forecast, shares fall after hours

Should Investors Hold on to Astera Labs Stock Post Q2 Earnings?

Astera Labs (ALAB) shares have fallen 12% since its Q2 2026 earnings report, primarily due to higher operating expenses despite strong demand for its AI connectivity products. The company's stock has outperformed the broader tech sector year-to-date, driven by its Scorpio, Aries, and Taurus …

Earnings call transcript: Establishment Labs tops revenue in Q2 2026, shares slip

Establishment Labs (NASDAQ:ESTA) Releases Earnings Results

BioAge Labs, Inc. Stock 12‑Month Price Target Cut to $35.62, Implies 224% Upside

BioAge Labs, Inc. (BIOA) has seen its average 12-month price target cut to $35.62 from $39.88, according to 8 analysts, yet this still implies a significant 224% potential upside based on its closing price. Despite the target reduction, the consensus rating from 9 analysts …

Astera Labs Beat And Guided Higher, Then Fell Because The Rally Came First

Image from Pixabay A record quarter and a guide above expectations met a stock that had already climbed for four straight sessions, and the mix underneath that growth is what actually changed. Astera Labs (ALAB), which sells connectivity silicon for rack-scale AI systems, reported …